Using real-world data, Song found that patients treated with CAR T-cell therapies had improved overall survival compared with ...

Former triathlon champ Claudia McCoy used the breakthrough wearable ultrasound unit to boost her recovery from injuries so she could push her friend's wheelchair from the start to the finish line.

EOM-613 is under clinical development by EOM Pharmaceuticals and currently in Phase II for Coronavirus Disease 2019 (COVID-19) Pneumonia.

Ruxolitinib phosphate is under clinical development by Incyte and currently in Phase III for Coronavirus Disease 2019 (COVID-19) Associated Cytokine Release Syndrome.

The randomized phase III AALL1731 trial presented at the American Society of Hematology annual meeting showed that adding the ...

Blinatumomab in addition to standard chemotherapy improved pediatric patients with NCI standard-risk B-cell acute lymphoblastic leukemia survival outcomes.

INR:3550. the daily life of the immortal king season 5 release date Breaking news! Chinese scientists reveal the mechani ...

Breaking news! Chinese scientists reveal the mechanism of CAR-T cells triggering cytokine release syndrome The meteorologica ...

Download Fortebet App FDA approves world's first intravenous drug for migraine prevention Detained for 10 days and fined 500 yuan! The latest prog ...

Giovanili beach volley Breaking news! Chinese scientists reveal the mechanism of CAR-T cells triggering cytokine release syndrome Can Pfizer's co ...

Merkur stavebnice New drug for major depression! GSK Bupropion Hydrochloride Sustained-Release Tablets (I) approved in China Breaking news! Chinese sc ...

INR:9314. live betpawa nolimit city demo rupiah Approved for clinical trials! I-Mab's TJM2 treats cytokine storm associated with COVID-19 Th ...